A Clinical Evaluation of Baofeikang Granule in Combined Pulmonary Fibrosis and Emphysema Treatment

NCT02805699 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Combined Pulmonary Fibrosis and Emphysema

Interventions

DRUG: Baofeikang Granule
DRUG: Placebo

Sponsor

Beijing Municipal Science & Technology Commission